These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1083239)

  • 41. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. II. Demonstration of an abnormal anti-complement property in rheumatoid synovial fluids].
    Peltier AP; Vial MC; Leroy C; de Sèze S
    Pathol Biol (Paris); 1970 Nov; 18(21):969-74. PubMed ID: 4099022
    [No Abstract]   [Full Text] [Related]  

  • 42. Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus.
    Gibofsky A; Winchester RJ; Patarroyo M; Fotino M; Kunkel HG
    J Exp Med; 1978 Dec; 148(6):1728-32. PubMed ID: 309927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction in vitro between synovial cells and autologous lymphocytes and sera from arthritis patients.
    Ghose T; Woodbury JF; Hansell MM
    J Clin Pathol; 1975 Jul; 28(7):550-8. PubMed ID: 1097473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Capellino S; Lowin T; Angele P; Falk W; Grifka J; Straub RH
    J Rheumatol; 2008 Jan; 35(1):91-9. PubMed ID: 18061980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells.
    Kumagai S; Ishida H; Iwai K; Tsubata T; Umehara H; Ozaki S; Suginoshita T; Araya S; Imura H
    Clin Exp Immunol; 1989 Dec; 78(3):348-53. PubMed ID: 2532990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T cell regulatory disturbances in the rheumatic diseases.
    Alpert SD; Koide J; Takada S; Engleman EG
    Rheum Dis Clin North Am; 1987 Dec; 13(3):431-45. PubMed ID: 2893438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serum and articular immune complexes detection by the antibody-dependent cytotoxicity inhibition reaction in inflammatory rheumatological conditions and connective tissue disorders (author's transl)].
    Meyer O; Descamps B; Ryckewaert A; Peltier A
    Nouv Presse Med; 1979 Mar; 8(14):1165-9. PubMed ID: 313556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

  • 49. Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion.
    Pérez-Sánchez C; Cecchi I; Barbarroja N; Patiño-Trives AM; Luque-Tévar M; Pérez-Sánchez L; Ibáñez-Costa A; Arias de la Rosa I; Ortega R; Escudero A; Castro MC; Radin M; Roccatello D; Sciascia S; Aguirre MÁ; Collantes E; López-Pedrera C;
    J Cell Mol Med; 2019 Sep; 23(9):6308-6318. PubMed ID: 31347786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphocyte studies in rheumatoid arthritis. II. Antibody-mediated and mitogen-induced lymphocyte cytotoxicity in synovial fluid and peripheral blood.
    Corrigall VM; Panayi GS
    Ann Rheum Dis; 1978 Oct; 37(5):410-5. PubMed ID: 718273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphocytotoxic antibody activity in cryoprecipitates from serum of patients with SLE.
    Zvaifler NJ; Bluestein HG
    Arthritis Rheum; 1976; 19(5):844-50. PubMed ID: 1085625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: a platelet specific immunoglobulin inducing the release reaction.
    Weissbarth E; Baruth B; Mielke H; Liman W; Deicher H
    Rheumatol Int; 1982; 2(2):67-73. PubMed ID: 6217534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
    Cohen S; Clowse M; Pardo P; Bhattacharya I; Menon S; Gourley I; Diehl A
    Clin Ther; 2016 Jun; 38(6):1417-1434.e2. PubMed ID: 27112532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.
    Cole S; Walsh A; Yin X; Wechalekar MD; Smith MD; Proudman SM; Veale DJ; Fearon U; Pitzalis C; Humby F; Bombardieri M; Axel A; Adams H; Chiu C; Sharp M; Alvarez J; Anderson I; Madakamutil L; Nagpal S; Guo Y
    Arthritis Res Ther; 2018 May; 20(1):85. PubMed ID: 29720240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Periodontitis and anti-neutrophil cytoplasmic antibodies in systemic lupus erythematosus and rheumatoid arthritis: a comparative study.
    Novo E; Garcia-MacGregor E; Viera N; Chaparro N; Crozzoli Y
    J Periodontol; 1999 Feb; 70(2):185-8. PubMed ID: 10102556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritis.
    Mota P; Reddy V; Isenberg D
    Expert Rev Clin Immunol; 2017 Jul; 13(7):667-676. PubMed ID: 27841031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complement-fixing activity of rheumatoid synovial fluid.
    Townes AS; Marcus RL
    Ann Rheum Dis; 1972 Sep; 31(5):393-401. PubMed ID: 5071634
    [No Abstract]   [Full Text] [Related]  

  • 59. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M; Dörner T; Burmester GR; Berek C
    Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCδ/ERK Signaling Pathway.
    He XJ; Ding Y; Xiang W; Dang XQ
    Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.